Dehydration News and Research

Latest Dehydration News and Research

Residents need to help elderly neighbors, relatives keep safe during the heat wave

With the first heat wave of the season poised to descend on the Northeast, Dr. Thomas Cavalieri, a geriatrician and the dean of the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine, is reminding residents to check on elderly neighbors and relatives who may not be aware of the dangers that come with hot weather.

29 May 2013

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Celgene International Sàrl, a subsidiary of Celgene Corporation today announced that the U.S. Food and Drug Administration has assigned a Priority Review designation to the supplemental New Drug Application for the use of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer.

23 May 2013

Study points to human body's limited ability to recover quickly following short-term weight loss

Athletes in combat sports often try to shed body weight in order to compete against lighter and smaller opponents. A new doctoral thesis from the University of Gothenburg, Sweden, points to the human body's limited ability to quickly recover following extensive short-term weight loss.

3 May 2013

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.

23 Apr 2013

Viewpoints: Boston hospitals, doctors rose to the challenge; Physicians need to understand health law to advise patients; Florida's budget problems could be eased by Medicaid expansion

If there is any silver lining in the violent Marathon attacks Monday, it is that Boston is home to some of the world's finest hospitals, physicians, nurses, and medical staff. These highly trained professionals must be thanked and praised for their calm, heroic response in the face of unprecedented carnage.

18 Apr 2013

Study suggests strain with Haiti cholera mutations may increase severity of disease

The cholera strain that transferred to Haiti in 2010 has multiple toxin gene mutations that may account for the severity of disease and is evolving to be more like an 1800s version of cholera, reports a new Northwestern Medicine study.

17 Apr 2013

Preventive measures to recover from hoarse voice

It's that time of year again, sports fans. We've marched through March Madness, when NCAA basketball playoff brackets bloomed and died and Cinderella stories rose from the shadows to revel in momentary glory.

6 Apr 2013

Fruit fly study offers clues to wound healing

A person's skin and a fruit fly's exoskeleton, called a "cuticle" may not look alike, but both coverings protect against injury, infection, and dehydration.

6 Apr 2013

Eight new grant recipients to receive funding to conduct health impact assessments

The Health Impact Project, a collaboration of the Robert Wood Johnson Foundation and The Pew Charitable Trusts, today announced eight new grant recipients that will receive funding to conduct health impact assessments, or HIAs.

2 Apr 2013

Novel sensor improves success rate in diagnosing dysphagia

Those suffering from swallowing difficulties, especially stroke patients, could be evaluated more efficiently and noninvasively thanks to research under way at the University of Pittsburgh and the University of Toronto.

27 Mar 2013

Clothing closely linked to peak performance for skiers

The sport of cross-country skiing has always been preoccupied with its skis and waxing. Research now demonstrates that to shave off those extra hundredths of a second, competitive skiers should pay more attention to their clothing.

3 Mar 2013

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) announced the U.S. Food and Drug Administration (FDA) has approved ABILIFY MAINTENA (aripiprazole) for extended- release injectable suspension, an intramuscular (IM) depot formulation indicated for the treatment of schizophrenia.

1 Mar 2013

Celgene receives FDA approval for POMALYST to treat multiple myeloma

Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.

10 Feb 2013

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.

28 Jan 2013

Ibuprofen and naproxen can cause kidney damage in children

Sick children, especially those with some dehydration from flu or other illnesses, risk significant kidney injury if given drugs such as ibuprofen and naproxen, Indiana University School of Medicine researchers said Friday.

25 Jan 2013

NSAIDs cause acute kidney injury in some children

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen, are commonly used to treat pain and reduce fever in children. However, the use of NSAIDs has been shown to cause acute kidney injury (AKI) in some children

25 Jan 2013

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved a new use of Avastin (bevacizumab) in combination with fluoropyrimidine-based irinotecan or oxaliplatin chemotherapy for people with metastatic colorectal cancer (mCRC).

23 Jan 2013

Cholera could be contained in Haiti by vaccinating less than half the population

Cholera could be contained in Haiti by vaccinating less than half the population, University of Florida researchers suggest in a paper to be published Thursday in the journal Scientific Reports.

11 Jan 2013

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).

2 Jan 2013

Winter is not a good excuse to give up fitness routines

The weather outside might be frightful, but sitting by that fire might make your fitness routine frightful. Though your body may be layered under sweatshirts and coats, staying active and healthy is important no matter what the temperature is outside.

27 Dec 2012

Dehydration News and Research

Latest Dehydration News and Research

Residents need to help elderly neighbors, relatives keep safe during the heat wave

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Study points to human body's limited ability to recover quickly following short-term weight loss

ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI

Viewpoints: Boston hospitals, doctors rose to the challenge; Physicians need to understand health law to advise patients; Florida's budget problems could be eased by Medicaid expansion

Study suggests strain with Haiti cholera mutations may increase severity of disease

Preventive measures to recover from hoarse voice

Fruit fly study offers clues to wound healing

Eight new grant recipients to receive funding to conduct health impact assessments

Novel sensor improves success rate in diagnosing dysphagia

Clothing closely linked to peak performance for skiers

Otsuka receives FDA approval for ABILIFY MAINTENA to treat schizophrenia

Celgene receives FDA approval for POMALYST to treat multiple myeloma

FDA approves Takeda’s NESINA, OSENI and KAZANO for treatment of type 2 diabetes

Ibuprofen and naproxen can cause kidney damage in children

NSAIDs cause acute kidney injury in some children

Genentech receives FDA approval for new use of Avastin plus chemotherapy to treat mCRC

Cholera could be contained in Haiti by vaccinating less than half the population

Crofelemer receives FDA approval for treatment of HIV associated diarrhea

Winter is not a good excuse to give up fitness routines

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dehydration News and Research

Latest Dehydration News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in